Dyslipidemia CASE 5A. Aling D., 62 years old female who came in for a General Check-up General Data.

Slides:



Advertisements
Similar presentations
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
Advertisements

« Systematic Cerebrovascular and cOronary Risk Evaluation » Global Cerebrovascular Risk Assessment SCORE - Canada « Systematic Cerebrovascular and cOronary.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Cardiovascular System KNH 411. Hypertension Nutrition Therapy DASH – Dietary Approaches to Stop Hypertension Decrease sodium, saturated fat, alcohol Increase.
ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
The Healthy Heart Figure 14.1.
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
Lipids 101 Cardiology Board Review Med-Peds Style!
Final Exam Tuesday, 6/5, 2 PM Closed book – Essay and MC/TF Determining Energy Needs – p – Indirect calorimetry – Be able to do the calculations.
Brooke Nessen Health Class (Grades 10-12) Explaining Cholesterol (Video)
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
Program Design Scenarios.  Data from medical / health questionnaire:  Age: 45 years  Height: 64 inches  Weight: 154lbs  Desired weight: 130lbs 
Cholesterol. CHOLESTEROL What is it? How does it cause heart disease? A fat like substance in your blood When there is too much cholesterol in your blood,
Risk Factors for Premature Atherosclerotic Heart Disease Dyslipidemia (high LDL, low HDL) Diabetes Hypertension Obesity Sedentary lifestyle Obesity Smoking.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
MI: Risk Factors and Primary Prevention. Risk Factors Factors that appear to increase the general population’s chances of experiencing a health problem.
Routine screening tests Hai Ho, M.D.. Most expensive part of medical practice? Your Pen.
LDL-C target levels (mg/dL)  2 RF:
Check the Lipid Profile? Why? Douglas W. Teske, MD The Heart Center Nationwide Children’s Hospital Douglas W. Teske, MD The Heart Center Nationwide Children’s.
Department of Family & Community Medicine
Nutrition and Cardiovascular Disease. Cardiovascular Disease Includes heart attack, stroke Includes heart attack, stroke Leading cause of death in the.
METABOLIC Syndrome: a Global Perspective
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Nursing Management of Clients with Stressors of Circulatory Function HYPERTENSION NUR133 LECTURE # 10 K. Burger MSEd,MSN, RN, CNE.
Coronary Artery Disease  Coronary artery disease is one of the most common and serious effects of aging. Fatty deposits build up in blood vessel walls.
Adi Kartolo University of Ottawa. Initial Presentation 42-year-old African-American male with type 2 diabetes Chief Complaint: increasing body weight.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Cardiovascular Disease. Caused by Atherosclerosis  Blocked artery By plaque Arteriosclerosis  “Hardening of the arteries”
Cholesterol and Triglycerides. What are triglycerides? Type of lipid found in your blood Store unused calories in your fat cells Hormones release triglycerides.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.
Cholesterol. What is cholesterol? Waxy, fat-like substance found in all cells. Dietary cholesterol – found only in animal-based foods Blood cholesterol.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention.
Global Cardiac Risk Management Anthony Battad CD, MD, MSc., MPH, FRCPC Director // Directeur Ambulatory Care, St. Boniface Hospital // Soins ambulatoire,
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention.
Laboratory Testing For Cardiovascular Risk
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
Cholesterol Measurement All adults should have their blood cholesterol measured every 5 years May be in non-fasting state Fasting preferred
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention Leslie Young MS RD LDN.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Presented by Slyter Nutrition Consulting Services.
FOURIER Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Cardiovascular Disease: Risk Factors and Risk Assessment
Physical Health and People with a Severe Mental Illness
Cholesterol practice questions
Cardiovascular System
National Cholesterol Education Program
Genes and environment in type 2 diabetes and atherosclerosis
Section 9: Continuum of care: Summary and timeline
Rational Order of Laboratory Tests in Cardiovascular Diseases
K June 03 03/06/20 1.
How to Optimize Cholesterol Management in High-Risk CV Patients
Goals & Guidelines A summary of international guidelines for CHD
Cardiovascular Disease in Women Module III: Risk Assessment Tool
PROSPER: trial design                                                                                                                                                                 
Preventative Cardiology
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
Insert Case Title Case Overview
Dyslipidemia And Diabetes
Case—History 75 year old woman referred for statin intolerance in 2016
National Cholesterol Education Month
Specific Dyslipidemias: Very High LDL Cholesterol (>190 mg/dL)
Presentation transcript:

Dyslipidemia CASE 5A

Aling D., 62 years old female who came in for a General Check-up General Data

Pertinent Information Aling D., 62/F, came in for general check-up Smoker (20-pack years) Frequently eats fatty food Sedentary lifestyle Father had history of ischemic cerebrovascular disease and MI at 38 y/o Urinalysis, CBG, EKG returned normal CXR: Atherosclerotic aorta PE: essentially unremarkable

Laboratory Results ParameterNormal ResultInterpretation Total Cholesterol <200 mg/dL; >/=240 mg/dL considered high 280 mg/dLHigh LDL <100 mg/dL optimal >/=190 mg/dL very high 190 mg/dLHigh HDL40-60 mg/dL50 mg/dLNormal Triglycerides<180 mg/dL145 mg/dLNormal

Step 1 Diagnosis and Risk Assessment

LOW RISK: < 3 of the following*  Hypertension  Familial hypercholesterolemia  LVH  Smoking  Family history of CAD  Male sex  Age > 55 years old  Proteinuria  Albuminuria  BMI ≥ 25 * CPG on Management of Dyslipidemia in the Philippines

Diagnosis and Risk Assessment LOW RISK: < 3 of the following*  Hypertension  Familial hypercholesterolemia  LVH  Smoking  Family history of CAD  Male sex  Age > 55 years old  Proteinuria  Albuminuria  BMI ≥ 25

Framingham Cardiac Risk Score

Primary Working Impression Dyslipidemia t/c metabolic syndrome Atherosclerosis High CV Risk

Step 2 Therapeutic Objectives

1. Lower cholesterol to normal levels pharmacologically 2. Reduce overall risk factors a. Smoking cessation b. Manage diet and promote active lifestyle c. Weight control (depends on his BMI and WHR) 3. Educate patient about medications (dosing, indications, adverse effects, etc.)